[HTML][HTML] A dynamic COVID-19 immune signature includes associations with poor prognosis

…, K Babalola, S Abdul-Jawad, J Cason, C Mant… - Nature medicine, 2020 - nature.com
Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

High-risk mucosal human papillomavirus infections during infancy & childhood

J Cason, CA Mant - Journal of clinical virology, 2005 - Elsevier
Human papillomaviruses (HPVs) are small DNA tumour viruses associated with a variety of
proliferative diseases. More than 100 types have been identified and can broadly be …

High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients

R Nath, C Mant, J Luxton, G Hughes… - Arthritis Care & …, 2007 - Wiley Online Library
Objective To determine rates of human papillomavirus (HPV) infections, abnormal cervical
smears, and squamous intraepithelial lesions (SIL) among women with systemic lupus …

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

…, K Babalola, S Abdul-Jawad, J Cason, C Mant… - MedRxiv, 2020 - medrxiv.org
Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency
because of its potential to cause life-threatening Covid-19 disease. By comparison to …

Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19

…, J Edgeworth, J Cason, C Mant… - Proceedings of the …, 2022 - National Acad Sciences
Whereas pathogen-specific T and B cells are a primary focus of interest during infectious
disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B …

A viral aetiology for breast cancer: time to re-examine the postulate

C Mant, S Hodgson, R Hobday, C D'Arrigo, J Cason - Intervirology, 2004 - karger.com
Despite decades of research, no aetiologic factor(s) for human breast cancer has been
identified and the search for a causal agent has all but been abandoned during the past thirty …

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

…, K Babalola, S Abdul-Jawad, J Cason, C Mant… - Nature medicine, 2020 - nature.com
In the version of this article initially published online, a statement of support was missing from
the Acknowledgements section. The correct ending of the fourth sentence of that section is …

[PDF][PDF] ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

…, S Pickering, R Roberts, A Waters, CC Ward, C Mant… - Cell Reports, 2022 - cell.com
Although the antibody response to COVID-19 vaccination has been studied extensively at
the polyclonal level using immune sera, little has been reported on the antibody response at …

A human murine mammary tumour virus‐like agent is an unconvincing aetiological agent for human breast cancer

C Mant, J Cason - Reviews in medical virology, 2004 - Wiley Online Library
There has recently been renewed interest in both the scientific literature, and in the media,
that a human relative (HMLV) of murine mammary tumour virus (MMTV) may be implicated in …

[HTML][HTML] The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

…, D Cox, C Ward, M Racz, A Waters, C Mant… - PLoS …, 2022 - journals.plos.org
COVID-19 vaccines are playing a vital role in controlling the COVID-19 pandemic. As SARS-CoV-2
variants encoding mutations in the surface glycoprotein, Spike, continue to emerge, …